retatrutide glp1 and the Grey Market: Buyer Beware – Sarah Hormachea GLP-1 Medications for Weight Loss:

A Pew Research Center survey conducted in February examined American attitudes toward weight-loss drugs and found that, while more than half of those familiar with the medications consider them a valuable weight loss option, 19% believe they are not, while 28% are unsure

What about the increased costs to our healthcare system

GLP-1 and the Nervous System GLP-1 receptors have been identified in numerous areas of the central nervous system (CNS) including the area postrema, hypothalamus, lateral parabrachial nucleus, nucleus accumbens, nucleus tract solitarius, and the vagal efferent neurons [106,107,108,109]

Maintenance plans focus on continued fitness plans, ongoing behavioral therapy, and periodic check-ins

Consider waiting for retatrutide if: You have severe obesity (BMI 40) and specifically need the difference between 15% and 28%+ weight loss a gap that matters clinically when 15% still leaves you in a high-risk range

[3] Healthcare providers should assess nutritional status based on individual risk factors and monitor for potential deficiencies, particularly in patients experiencing significant weight loss or persistent gastrointestinal symptoms